BRIEF-European commission approves Bristol-Myers Squibb's opdivo

BRIEF-European commission approves Bristol-Myers Squibb's opdivo


* Applied to TSX venture exchange for approval to extend exercise date for 2. 5 million outstanding warrants issued in June 2015 Source text for Eikon: Further company coverage:



from Biotech News